Vy Ngo is investigating chemotherapy resistance

1. Welcome back to the TBCRU, can you remind our readers who you are and tell us a little about yourself? My name is Vy Ngo, and I am a Ph.D. candidate in the Department of Pathology and Laboratory Medicine at Western University. I work under Dr. Martin Duennwald, and this is my third year […]

Vy Ngo is investigating chemotherapy resistance in HER2+ breast cancer

1. Welcome back to the TBCRU, can you remind our readers who are you and tell us a little bit about yourself. My name is Vy Ngo, and I am a Ph.D. candidate in the Department of Pathology and Laboratory Medicine at Western University, working under the supervision of Dr. Martin Duennwald. I completed my […]

Dr. Ryan Holloway’s goal is to prevent breast cancer recurrences.

1. Who are you? Tell us about yourself. I am Dr. Ryan Holloway, a postdoctoral fellow under the supervision of Dr. Paola Marignani at Dalhousie University. I also received my Ph.D. (Pathology), MSc. (Biochemistry), and undergraduate degree (Biology) at Dalhousie University. 2. Why is your BCSC research grant important to you? The financial support from […]

The Triple Negative Breast Cancer Battlefield

New Tools for Testing Therapies How do we attack an enemy we can’t even see? This is the challenge doctors and scientists face when they come head-to-head with Triple Negative Breast Cancer (TNBC). This subtype is called “triple negative” because it lacks any of the three principle markers found on other forms of breast cancer: […]

Blocking the cancer-related signal in HER2 breast cancer

Greetings! My name is Xuguang Liu and I’m a PhD candidate in the Department of Biochemistry at Western University, working with Dr. Shawn Li. We’re focused on cancer system biology and exploring the potential applications of our research in the treatment of HER2 positive breast cancer. HER2 positive breast cancer is diagnosed as overactivity of […]